Status:
COMPLETED
Effect of an Inhibitor of Cholesterol Absorption on Vitamin D Levels
Lead Sponsor:
Federal University of Rio Grande do Sul
Conditions:
Vitamin D Deficiency
Eligibility:
All Genders
18-40 years
Phase:
PHASE4
Brief Summary
Double-blind randomized controlled trial to evaluate the serum levels of 25(OH)D after a single oral dose of cholecalciferol 50,000 IU plus ezetimibe or placebo. Differences between the serum levels ...
Detailed Description
Objectives: To evaluate the serum levels of 25(OH)D after a single oral dose of cholecalciferol 50,000 IU plus ezetimibe or placebo. Experimental design: Double-blind randomized controlled trial. Res...
Eligibility Criteria
Inclusion
- Medical students of the HCPA
Exclusion
- Body mass index \>+ 25 or \< 18.5 kg/m2
- Known liver, kidney or endocrine disease
- Known malabsorption
- Use of supplements of calcium and/or vitamin Danticonvulsants, barbiturates, or glucocorticoids
- Travel outside the Brazilian south region during the previous 120 days
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT02234544
Start Date
October 1 2014
End Date
April 1 2015
Last Update
April 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903